Tasneen Mohammad
Dermatology · Detroit, MINPI 1962820696
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,525 of the $8,892 with a category attached, or 73.4%. Incyte Corporation accounts for 76.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $7,628 and has fallen 98.3% since, to $129 in 2025.
Across 29 payments — averaging $306.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$7K
- Avita Medical Americas, LLC$764
- Novartis$237
- AbbVie$217
- Johnson & Johnson$170
- LEO Pharma Inc.$137
- plus $605 from 6 others
Across 10 payments — averaging $5273.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tanabe Pharma America, Inc.$50K
- Pfizer$3K
What the payments were for
- Consulting fees$6,52573%
- Travel & lodging$85610%
- Food & beverage$1,41116%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 10 | $6,761 |
| Avita Medical Americas, LLC | 3 | $764 |
| Novartis | 2 | $237 |
| AbbVie(2 entities) | 3 | $217 |
| Johnson & Johnson(2 entities) | 2 | $170 |
| LEO Pharma Inc. | 2 | $137 |
| Galderma Laboratories, L.p. | 1 | $131 |
| Janssen Scientific Affairs, LLC | 1 | $123 |
| Pfizer | 1 | $120 |
| Regeneron Healthcare Solutions, Inc. | 1 | $114 |
| Sanofi | 2 | $102 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,892 in reported general payments places this provider in the 80th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 30 | $136,656 |
| Humira PenAdalimumab | 12 | $71,704 |
| RinvoqUpadacitinib | 11 | $67,960 |
| OpzeluraRuxolitinib Phosphate | 21 | $39,667 |
| Calcipotriene | 21 | $3,892 |
| Clobetasol Propionate | 64 | $1,708 |
| Tacrolimus | 13 | $1,325 |
| Ketoconazole | 80 | $1,299 |
| Triamcinolone Acetonide | 80 | $1,053 |
| Ammonium Lactate | 40 | $928 |
| Clindamycin Phosphate | 26 | $685 |
| Fluocinolone Acetonide | 19 | $616 |
| Metronidazole | 16 | $517 |
| Doxycycline Hyclate | 29 | $464 |
| Hydrocortisone | 55 | $329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $217 | $67,96011 claims |
| Incyte CorporationOpzelura | $6,761 | $39,66721 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 404 dermatology providers in Michigan.
Other dermatology in Detroit
- Karen HeidelbergDetroit$14K
- Richard HugginsDetroit$11K
- Linda Stein GoldWest Bloomfield$3.3M
- Kristi HawleyCaledonia$2.2M
- David AltmanWarren$1.9M
- Michael SiegelWaterford$708K
- Johann GudjonssonAnn Arbor$535K
- Michael DormanWest Bloomfield$433K
- Steven DaveluyDearborn$350K
- Benjamin WorkmanMidland$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.